CVB vs SPL

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CVB

CURVEBEAM FPO [CVB]

49LOW

SPL

STARPHARMA FPO [SPL]

49LOW

Score Breakdown

CVB SPL
Technical
48
48
Catalyst
52
65
Sentiment
50
50
Fundamental
52
72
Momentum
49
82
Risk Gate
37
50

Key Metrics

CVB Metric SPL
$22.0MMarket Cap$195.3M
375KAvg Volume (20d)1.7M
+0.2%Short Interest+0.1%
$0.17552-Week High$0.525
$0.04552-Week Low$0.082
+6.5%Daily Change+0.0%
$0.049Entry Price$0.465
-41.8%ROE-14.5%
-133.1%Profit Margin-22.2%

Active Signals

CVB Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (1.8x)
●Piotroski F-Score weak (2/9, low-confidence approx)

SPL Signals

●Stochastic is stretched into overbought — could need a breather
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)
●Moderate P/S ratio (13.4x)
●Strong revenue growth (+360%)
●EPS estimates revised downward (-10pts)

Ask Scout AI to compare CVB and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CVB Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).